Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Bünde – page 21

618 clinical trials in Bünde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Bünde at a glance
618
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

618 trials in Bünde

Open in trial search

Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Faecal Microbiota, Pooled
  • Sponsor:Maat Pharma

Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Antwerp University Hospital

Study on Hydrochlorothiazide and Tolvaptan for Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Hydrochlorothiazide
  • Sponsor:Universitair Medisch Centrum Groningen

Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH

Neoplasm

Recruiting

Study on the Safety and Effectiveness of IMA402, Tocilizumab, and Human Serum Albumin for Patients with Recurrent or Resistant Solid Tumors

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Decitabine
  • Sponsor:Immatics Biotechnologies GmbH

Phase III Trial Comparing ABVD vs A2VD Treatment With PET-Guided Radiation Therapy for Patients With Early Stage Hodgkin Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin
  • Sponsor:University College London

Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Universitair Medisch Centrum Utrecht

Vulval cancer

Recruiting

Study Comparing Chemoradiation and Chemotherapy with Cisplatin, Paclitaxel, and Carboplatin for Patients with Advanced Vulvar Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Rectal cancer

Recruiting

Study of drug combination (capecitabine, fluorouracil, oxaliplatin, calcium folinate) to prevent cancer recurrence in patients with detectable ctDNA after rectal cancer surgery

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study Comparing Trifluridine/Tipiracil with Panitumumab or Bevacizumab for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Study on [68Ga]FAPI-46 to Detect Fibroblast Activity in Patients with Non-Resolving Acute Respiratory Distress Syndrome (ARDS) in the ICU

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:68Ga-FAPI-46
  • Sponsor:Universitair Medisch Centrum Groningen

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Bünde

What the registry says about research in the country

01 Nutritional and Metabolic Diseases

The clinical trial activity in Bünde is centered on Nutritional and Metabolic Diseases, with studies focused on improving care for obesity, overweight, and type 2 diabetes. These trials are mainly testing new treatment approaches and assessing how well they support weight management and blood sugar control.

  • Weight-related treatment studies in obesity and overweight
  • Type 2 diabetes research aimed at better glycaemic control
  • Trials exploring therapy effectiveness in people with combined metabolic conditions
  • Clinical research designed to improve everyday treatment options

Several studies also connect metabolic health with other conditions, showing a broad interest in practical treatment strategies for patients in routine care.

02 Kidney Disease Research

One important area of research in Bünde involves chronic kidney disease, with trials examining whether new treatment combinations can help preserve kidney function. The goal is to evaluate treatment effectiveness and support better long-term kidney health.

  • Chronic kidney disease as a key focus of ongoing research
  • Studies assessing kidney function outcomes
  • Testing new therapeutic combinations for improved disease control

This work reflects a strong interest in finding more effective options for people living with progressive kidney problems.

03 Obesity and Weight Management

Clinical trials in the area of obesity and overweight are exploring whether new therapies can support meaningful body weight reduction. These studies are aimed at evaluating treatment benefit in people who need better options for long-term weight control.

  • Obesity and overweight as main conditions under study
  • Research focused on weight change and treatment response
  • Testing new approaches for healthier metabolic outcomes

The trials address an important area of public health by looking for more effective ways to manage excess weight.

04 Metabolic Disease and Diabetes Care

Another major theme is type 2 diabetes management, where trials are comparing treatment approaches to see how well they maintain blood sugar levels in real-world practice. The emphasis is on improving treatment effectiveness for people who already use glucose-lowering medication.

  • Type 2 diabetes treatment optimization
  • Comparisons of longer-acting and daily insulin-based options
  • Focus on sustained blood sugar control over time

These studies may help shape more practical and patient-friendly diabetes care strategies.

05 Osteoarthritis and Joint Pain

Research also includes osteoarthritis, especially knee pain linked with obesity or overweight. The trials are looking at ways to ease joint symptoms while also supporting weight-related health goals.

  • Osteoarthritis with a focus on knee pain
  • Studies involving people with obesity or overweight
  • Evaluation of symptom relief and functional improvement

This area connects musculoskeletal care with metabolic health, reflecting the close relationship between body weight and joint discomfort.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.